XTL Biopharmaceuticals Ltd.
(NASDAQ : XTLB)

( )
XTLB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -11.87%310.610.0%$5071.29m
BNTXBioNTech SE -4.91%334.480.0%$1509.60m
NVAXNovavax, Inc. -7.66%192.6578.2%$1000.81m
AMGNAmgen, Inc. 0.97%200.801.4%$596.73m
GILDGilead Sciences, Inc. 0.00%68.931.0%$502.66m
REGNRegeneron Pharmaceuticals, Inc. -0.93%630.592.7%$480.14m
VRTXVertex Pharmaceuticals, Inc. 9.66%205.001.9%$469.49m
LGVNLongeveron Inc. -22.20%20.430.0%$404.67m
ILMNIllumina, Inc. -2.10%357.663.3%$316.55m
SNSSSunesis Pharmaceuticals, Inc. -10.85%4.110.7%$287.30m
BIIBBiogen, Inc. -2.65%229.501.8%$286.58m
OCGNOcugen, Inc. -4.89%6.030.0%$251.60m
INCYIncyte Corp. -4.08%64.962.4%$161.20m
EXASEXACT Sciences Corp. -5.96%80.2818.0%$157.41m
SGENSeagen Inc. -1.09%158.255.8%$147.19m

Company Profile

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.